Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure showing Functional Reversal and Myocardial Rejuvenation ...Middle East

NIJMEGEN, Netherlands, Nov. 4, 2020 /PRNewswire/ -- Saillant Therapeutics, an innovative preclinical stage biotechnology company developing promising small molecule-based therapies, today announced that it has obtained Proof of Concept for its lead compound (ST02) indicated for the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure showing Functional Reversal and Myocardial Rejuvenation )

Also on site :

• Opinion: Tolerance of diversity is central to San Diego’s economic growth
• De Anza College physical education complex to undergo $53 million renovation
• Gold ETFs see largest inflows in five years amid trade war concerns: WGC